Singapore eDevelopment Ltd (SeD) is pleased to announce that its U.S. biomedical subsidiary Global BioLife Inc. has developed 3F Antimicrobial
MoreAlmost two decades of intensive research may soon lead to a major development in the search for a treatment of
More